Александр Васильевич Пивник - Гематолог, Заслуженный врач РФ, Профессор, Доктор медицинских наук
Новости
Биография
Амбулаторный прием
Темы и проблемы
Цели и задачи
Научные труды
Ученики и коллеги
Контакты
Объявления



 

ТЕМЫ И ПРОБЛЕМЫ

Анемии

 

ГЕННАЯ ТЕРАПИЯ В ЛЕЧЕНИИ АНЕМИИ:

Обновление 15.04.05:

A novel mechanism in suppression of erythropoiesis during inflammation: a crucial role of RCAS1.

Suehiro Y, Muta K. 2005.

Anemia and Gene Therapy — A Matter of Control.

Katherine High, M.D. 2005.

 

Аранесп (дарбопоэтин альфа): информация о препарате:

 

Обновление 7.03.05:

Аранесп (дарбопоэтин альфа) - Общие данные о препарате.

Доказанная безопасность препарата.

История открытия препарата.

Преимущества для пациентов.

Преимущества практического применения.

Стойкое влияние на эритропоэз.

Улучшенная структура молекулы способствует постоянной концентрации препарата в сыворотке крови.

     

    Эритропоэтин- препарат в лечении АНЕМИИ:

     

    Обновление 25.03.05:

Erythropoietin a drug that saves lives.

Philippe Cramer. 2005.

Clinical experience with darbepoietin alfa (NESP) in children undergoing hemodialysis.
De Palo T, Giordano M. Pediatr Nephrol. 2004.

Comparison of the serum erythropoietin levels in chemotherapy-naive and cisplatin-treated cancer patients.

Arslan M. Neoplasma. 2005.

Erythropoietic response to anemia in chronic hepatitis C patients receiving combination pegylated interferon/ribavirin.
Balan V.Am J Gastroenterol. 2005.

Darbepoetin alpha for the treatment of anaemia in low-intermediate risk myelodysplastic syndromes.
Musto P. Br J Haematol. 2005.

Darbepoietin alfa potentiates the efficacy of radiation therapy in mice with corrected or uncorrected anemia.
Ning S, Hartley C. Cancer Res. 2005.

Erythropoietin.
Carlo Brugnara. 2004.

Erythropoietin.
Karl G. Blume. 2004.

Erythropoietin, uncertainty principle and cancer related anaemia
JG Kelton H. 2004.

Erythropoietin in the Anemia of Malignancy.
Dr. Kevin Imrie. 2003.

Erythropoietin as an angiogenic factor.
D. Ribatti. 2003.

Erythropoietin Is Beneficial in Mitomycin-Induced Hemolytic-Uremic Syndrome.
C. Catalanoa. 2002.

Erythropoietin, Iron and Red Blood Cell.
Carlo Brugnara. 2000.

Gudance on clinical trial design for Biosimilar Epoetin.


Все ли эпоэтины одинаковы по своей эффективности и безопасности?

Применение Рекормона® (человеческого рекомбинантного эритропоэтина) в лечении эритропоэтиндефицитных анемий у детей и подростков.

Рекормон - эпоэтин бета.

Пособие для врачей-гематологов и педиатров. 2004. 

Рекомбинантный человеческий эритропоэтин альтернатива гемотрансфузиям.
Е.Ф. Морщакова. 2003. 

Рекормон (Recormon).

Инструкция по медицинскому применению препарата.


ПАРЦИАЛЬНАЯ КРАСНОКЛЕТОЧНАЯ АПЛАЗИЯ:

 

Парциальная Красноклеточная Аплазия Костного Мозга. АВ Пивник. Руководства по гематологии, 2005, том 3.

Эпоэтин-альфа индуцированная парциальная красноклеточная аплазия. Клинический случай.
Студент 6 курса Ликунов Е.Б. Февраль 2005.

Анемия Diamond-Blackfan, редкая наследственная форма парциальной красноклеточной аплазии.
Обзор литературы Ликунова Е. Б.
Ноябрь 2004.

Pure Red-Cell Aplasia and Epoetin Therapy.

Anna Solovey. 2004.

Diamond-Blackfan Anemia: In Vitro Response of Erythroid Progenitors to the Ligand for c-kit.

By Janis L. 2004.  

Molecular basis of Diamond-Blackfan anemia:new findings from the Italian registry and a review of the literature.

Maria Franciesca. 2004.

LOUIS DIAMOND and his contribution to HAEMATOLOGY.

Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?

Nevin YALMAN. 2004.

Use of rituximab to treat refractory Diamond-Blackfan anemia.

Morimoto A. 2005.

    СТАТЬИ ИНОСТРАННЫХ ЖУРНАЛОВ:

    Обновление 8.01.05:

Anemia in Adults: A Contemporary Approach to Diagnosis.
Carlo Brugnara. 2003.

Fanconi anemia proteins promote the four Rs: Replication, recombination, repair, and recovery.
Thompson LH. Environ Mol Mutagen. 2005.

Aplastic Anemia.
Hänel Chemnitz. 2002.

Application of Automated HPLC in Prenatal Diagnosis of Thalassemia.
Pranee Winichagoon. 2002.

Automated HPLC in Prenatal Diagnosis of Thalassemia.
Suthat Fucharoen. 2002.

Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation.
Carlo Brugnara. 2003.

Eritropoesis and serum sVCAM-1 levels in adults with sickle ceii disease.
Carlo Brugnara. 2000.

Guidelines for the diagnosis and management of Acquired Aplastic Anemia.
British Journal of Haematology. 2003.

Increased circulation levels of soluble HLA class I heterodimers in pations with sickle cell disease.
Moore C. 1998.

Inhibition of Eritroid Progenitor Cells by Anti-Kell Antibodes in Fetal Alloimmune Anemia.
Janet I. 1998.

Long-term followup of patients treated with Rituximab for ITP.
A.A.N. Giagounidis. 2003.

Massive Hemolysis and Methemoglobinemia in a Toddler.
Kimberly P. 2000.

Microcytic Red Cell Disorders in British Asian Children.
Rod Hinchliffe. 2000.

Neonatal Anemia.
Carlo Brugnara. 2004.

Neonatal transfusion practice.
Arch Dis Child. 2004.

Perniciosus Anemia.
Ban-Hock Toh. 1997.

Peripheral Blood Tests in Iron Deficiency Anemia Diagnosis.
Alan Mast, MD. 2000.

Protein C and S and imflammation in sickle cell disease.
Schnog JB. 2004.

Polycythemia Vera: A Comprehensive Review and Clinical Recommendations.
Carlo Brugnara. 2003.

Recombinant Erythropoietin for the Treatment of Anemia in Inflammatory Bowel disease.
Stefan Schreiber. 1996.

Serological and Clinical Aspects of Autoimmune Hemolytic Anemias.
A. Salama. 2002.

Successful treatment of steroid refractory severe autoimmune hemolytic anemia with Rituximab.
T. Schanz, M. 2003.

The Clinical Utility of Peripheral Blood Tests in the Diagnosis of Iron Deficiency Anemia.
Alan Mast, MD. 2001.

The effect of hydroxyurea on coagulation system in sickle cell anemia and beta-thalasemia intermedia pat.
Koc A, Gumruk. 2003.

The Pathophysiology of Acqured Aplastic Anemia.
Neal S. Young. 1997.

The Thalassemia Syndromes.
D J Weatherall. 2001.

 

АНЕМИЯ ПРИ ЗЛОКАЧЕСТВЕННЫХ ЗАБОЛЕВАНИЯХ:

Анемия при злокачественных опухолях.

В.В. Бредер. 2003.

Anemia and HIV in the Antiretroviral Era: Potential Significance of Testosterone.

Caroline Behler. 2005.

Анемия при злокачественных новообразованиях: патогенез и лечение рекомбинантным человеческим эритропоэтином.
А.Д. Павлов, Е.Ф. Морщакова, А.Г. Румянцев. 2003.

Анемия беременных.
М.В.Хитров, M.Б.Охапкин, И.Н.Ильяшенко. Обзорная лекция. 2004.

Хроническая железодефицитная анемия.
А.В. Пивник. 2002.

Anemia in Cancer.
Mark H. Greene.  2004.

Anemia & Cancer.
Rainer Storb. 2001.

Anemia in Men With Advanced Prostate Cancer: Incidence, Etiology, and Treatment.
Celal Deveciogy. 2004.

Cancer incidence in persons with Fanconi anemia.
Philip S. Rosenberg. 2003.

 

СТАТЬИ ИНОСТРАННЫХ ЖУРНАЛОВ:

 

A Peutz-Jeghers syndrome case with iron deficiency anemia and jejuno-jejunal invagination.
Hac Mehmet Soum Kmen. 2003.

Acquired hemolytic anemia.
JG Kelton H. 2004.

Acquired Hemolytic Anemias.
G. N. Kakepoto, S. 2003.

Anemia.
Harvey Simon, MD. 2004.

Anemia Diagnosis, Classification, and Monitoring Using Cell-Dyn Technology Reviewed for the New Millennium.
L. Van Hove. 2000.

Autoimmune Hemolytic Anemia in a Patient with Primary Ovarian Non-Hodgkin's Lymphoma.
Chang Kil Jung.  2004.

Congenital dyserythropoietic anemias: epidemiology, clinical significance, and progress in understanding their pathogenesis.
Hac Mehmet Sum. 2003.

Cyclophosphamide and Antithymocyte Globulin to Condition Patients With Aplastic Anemia for Allogeneic Marrow Transplantations:
Rainer Storb. 2001.

Dydrogesterone-induced hepatitis and autoimmune hemolytic anemia.
Dilec A. 2003.

Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera.
Raffaele Landolfi. 2004.

Effectiveness and Safety of an Induction Therapy with Epoetin Alfa in Anemic Cancer Patients Receiving Concomitant Chemotherapy.
Enrico Kortesi. 2004.

Hemolytic Anemia.
Gurpreet Dhaliwal. 2004.

Hemolytic Anemia.
J.L. Jenkins, MD. 2001.

Immunosuppressive Therapy-Induced Hepatotoxicity in Patients with Aplastic Anemia.
Yacutemdat Dyacute Lek. 2000.

Morbidity and Mortality of Chronic GVHD After Hematopoietic Stem Cell Transplantation From HLA-Identical Siblings for Patients With Aplastic or Refractory Anemias.
Martin Goerner. 2001.

Measurements of Red Cell Parameters in alpha-Thalassemia Trait: Correlation With the Genotype.
Chen Wang. 2000.

Marrow Transplants From Unrelated Donors for Patients With Aplastic Anemia: Minimum Effective Dose of Total Body Irradiation.
Michael. D. 2002.

Molecular basis of thalassemia.
Dr. P. C. Giordano. 2004.

Morbidity and Mortality of Chronic GVHD After Hematopoietic Stem Cell Transplantation From HLA-Identical Siblings for Patients With Aplastic or Refractory Anemias.
Martin Goerner. 2002.

Microangiopathic Hemolytic Anemia, Thrombocytopenia and Acute Renal Failure Associated with Acute Brucellosis.
Murat Soumker, MD. 2001.

Normocytic Anemia.
Dr. D. Lee. 2004.

Polycythemia Vera and Idiopathic Erythrocytosis Comparison of Clinical and Laboratory Parameters.
M. Usman. 2004.

Pulmonary Tuberculosis Associated with Autoimmune Hemolytic Anemia:
Mehmet Turgut. 2002.

Reticulocyte A n a lysis Provided by the Coulter GEN.S: Significance and Interpretation in Regenerative and Nonregenerative Hematologic Conditions.
CH. Fourcade. 2000.

Reticulocyte Counting in Thalassemia Using Different Automated Technologies.
Pornavaree Lamchiagdhase. 2000.

Regulation of Expression of the Human Erythropoietin Receptor Gene.
Stuart S. Winter. 1996.

Stable Mixed Hematopoietic Chimerism After Bone Marrow Transplantation for Sickle Cell Anemia.
M.C. Walters. 2001.

Thalassemia.
Theodore Gooley. 2004.

The Use and Interpretation of Quantitative Terminology in Reporting of Red Blood Cell Morphology.
Lawrence Hookey. 2000.

Ticlopidine Induced Anemia and Agranulocytosis.
Ali Kesk Yacute N. 2000.